INSMED Inc — Director's Dealing 2022

May 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-05-23

Reporting Person: Wise John Drayton (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-23	Common Stock	A	26236	—	Acquired	78137	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-23	Stock Option (right to buy)	$20.01	A	164580	Acquired	2032-05-23	Common Stock (164580)	Direct

Footnotes

F1: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant, subject to Mr. Wise's continued employment with the Company on each vesting date.

F2: Each Restricted Stock Unit was received as a grant on May 23, 2022, for no consideration.

F3: In connection with the appointment of Mr. Wise as the Company's Chief Commercial Officer, the Company granted Mr. Wise an option to purchase a total of 164,580 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Wise's continued employment with the Company on each vesting date.